Skip to main content

Advertisement

Log in

Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism

  • Original Article
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

Venous thromboembolism (VTE) is a multifactorial disease determined by a combination of inherited and acquired factors. Inherited factors include mutations in the genes coding for coagulation factors, some of which seem to exert a differential influence on the risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE). In post-mortem studies of subjects who have died from pulmonary embolism (PE), the analysis of the factors that may have augmented the VTE risk is often limited to acquired factors. This is due to the complexity—and sometimes the unfeasibility—of analyzing genetic factors and to insufficient knowledge of their individual roles in PE development. The present study used formalin-fixed paraffin-embedded (FFPE) tissue to investigate a panel of 12 polymorphisms—the largest ever studied—that affect the VTE risk. Tissue samples came from post-mortem examinations performed by the specialists of the Section of Legal Medicine of the Department of Pathology of Marche’s Polytechnic University, and by the specialists of Health Care District Hospital of Imola, on 44 subjects who died from PE in the period 1997–2014. All individuals were found to have at least one mutation affecting the VTE risk. The present study demonstrates that genetic analysis can be performed post-mortem and the results are useful for forensic investigations, especially from MTHFR C677T and PAI-1 4G/5G polymorphisms. Broader studies using the techniques described herein are needed to determine the relative influence of the individual polymorphisms and their interaction in PE deaths.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mäkelburg AB, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Lijfering WM (2010) Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. Haematologica 95(6):1030–1033

    Article  PubMed  Google Scholar 

  2. Bounameaux H (2000) Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 356(9225):182–183

    Article  CAS  PubMed  Google Scholar 

  3. Kuismanen K, Savontaus ML, Kozlov A, Vuorio AF, Sajantila A (1999) Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample. Forensic Sci Int 106(2):71–75

    Article  CAS  PubMed  Google Scholar 

  4. Vandenbroucke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JH, Manten B, Reitsma PH (1998) Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 79(3):511–516

    CAS  PubMed  Google Scholar 

  5. Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D (2002) The −33T → C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 88(2):195–199

    CAS  PubMed  Google Scholar 

  6. Fineschi V, Bafunno V, Bello S, De Stefano F, Margaglione M, Neri M, Riezzo I, Turillazzi E, Bonsignore A, Vecchione G, Ventura F, Grandone E (2012) Fatal pulmonary thromboembolism. A retrospective autopsy study: searching for genetic thrombophilias (factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus. Forensic Sci Int 214(1–3):152–158

    CAS  PubMed  Google Scholar 

  7. Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism. A meta-analysis involving approximately 120, 000 cases and 180, 000 controls. Thromb Haemost 102(2):360–370

    CAS  PubMed  Google Scholar 

  8. Luyendyk JP, Tilley RE, Mackman N (2006) Genetic susceptibility to thrombosis. Curr Atheroscler Rep 8(3):193–197

    Article  CAS  PubMed  Google Scholar 

  9. Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010) Functional characterization of polymorphisms in the human TFPI gene. Biochem Biophys Res Commun 397(1):106–111

    Article  CAS  PubMed  Google Scholar 

  10. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–3069 3069a-3069k

    Article  CAS  PubMed  Google Scholar 

  11. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107(8):1117–1122

    Article  Google Scholar 

  12. Zappacosta B, Romano L, Persichilli S, Cutrone LA, Graziano M, Vitrani A, Di Castelnuovo A, Giardina B, Musumeci S, Mastroiacovo P (2009) Genotype prevalence and allele frequencies of 5, 10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Italian newborns. Lab Medicine 40(12):732–736

    Article  Google Scholar 

  13. Faioni EM, Castaman G, Asti D, Lussana F, Rodeghiero F (2004) Association of factor V deficiency with factor V HR2. Haematologica 89(2):195–200

    CAS  PubMed  Google Scholar 

  14. Menegatti M, Asselta R, Duga S, Malcovati M, Bucciarelli P, Mannucci PM, Tenchini ML (2001) Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein. Thromb Res 103(4):299–307

    Article  CAS  PubMed  Google Scholar 

  15. Saibeni S, Vecchi M, Faioni EM, Franchi F, Rondonotti E, Borsi G, de Franchis R (2003) Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease. Dig Liver Dis 35(1):32–36

    Article  CAS  PubMed  Google Scholar 

  16. Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF (1998) Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 82(4):524–525

    Article  CAS  PubMed  Google Scholar 

  17. Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010) Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 8:7

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adriano Tagliabracci.

Ethics declarations

Ethical approval

For this type of study, formal consent is not required.

Additional information

Francesco Brandimarti and Federica Alessandrini contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brandimarti, F., Alessandrini, F., Pesaresi, M. et al. Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism. Int J Legal Med 131, 447–458 (2017). https://doi.org/10.1007/s00414-016-1508-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-016-1508-z

Keywords

Navigation